Clinical Trials Browser

Phase 3 × Arsenic Trioxide × Lymphoid × Clear all

NCT02757040 2016-04-29

Combination of Ibrutinib and As2O3 in the Treatment of CLL

Phase 3 Unknown

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell